EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease

Sasivimol Virameteekul iD, Andrew J Lees iD, Roongroj Bhidayasiri iD

Movement Disorders · 2024-11 · 39 (11) · 1922-1937

DOI: 10.1002/mds.29939 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Movement Disorders, online erschienen am 30.07.2024. Verfasst von Sasivimol Virameteekul und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Parkinson Disease, Polymers, Nanoparticle Drug Delivery System. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 143 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the availability of a number of efficacious treatments for Parkinson's disease, their limitations and drawbacks, particularly related to low brain bioavailability and associated side effects, emphasize the need for alternative and more effective therapeutic approaches. Nanomedicine, the application of nanotechnology in medicine, has received considerable interest in recent years as a method of effectively delivering potentially therapeutic molecules to the brain. In particular, polymeric nanoparticles, constructed from biodegradable polymer, have shown great promise in enhancing therapeutic efficacy, reducing toxicity, and ensuring targeted delivery. However, their clinical translation remains a considerable challenge. This article reviews recent in vitro and in vivo studies using polymeric nanoparticles as drug and gene delivery systems for Parkinson's disease with their challenges and future directions. We are also particularly interested in the technical properties, mechanism, drugs release patterns, and delivery strategies to overcome the blood–brain barrier. © 2024 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseasePolymersNanoparticle Drug Delivery SystemAnimalsHumansAntiparkinson AgentsBlood-Brain Barrier

Stichwörter der Autor:innen

Parkinson's diseaseadvanced therapiesdrug deliverynanomedicinepolymeric nanoparticles

Substanzen

Antiparkinson AgentsPolymersNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology, London, UK.
  • Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, B…
  • The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.

ORCID-Profile: Sasivimol Virameteekul, Andrew J Lees, Roongroj Bhidayasiri

Zitieren

APA

Virameteekul, S., Lees, A. J., & Bhidayasiri, R. (2024). Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease. Movement Disorders, 39(11), 1922-1937. https://doi.org/10.1002/mds.29939

Vancouver

Virameteekul S, Lees AJ, Bhidayasiri R. Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease. Movement Disorders. 2024;39(11):1922-1937. doi:10.1002/mds.29939

BibTeX
@article{Virameteekul2024,
  author = {Virameteekul, Sasivimol and Lees, Andrew J and Bhidayasiri, Roongroj},
  title = {Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease},
  journal = {Movement Disorders},
  year = {2024},
  volume = {39},
  number = {11},
  pages = {1922--1937},
  doi = {10.1002/mds.29939}
}
Kostenlos starten →